China vs Singapore: Hepatitis B (HepB3) immunization coverage among 1-year-olds (%)
China
96.0%
in 2025
Singapore
96.0%
in 2025
China rank
40th
Singapore rank
40th
Hepatitis B (HepB3) immunization coverage among 1-year-olds (%) over time
- China
- Singapore
How they compare
China currently reports 96.0% against 96.0% in Singapore, a difference of 0.0%.
The two have swapped places 2 times across 26 shared years of data; in 2000 it was Singapore ahead.
China ranks 40th and Singapore ranks 40th of 194 countries.
Across the 3 decades both report, China averaged higher in 2 and Singapore in 1.
Head to head by decade
| Decade | China | Singapore | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 81.0% | 95.6% | 14.6% | Singapore |
| 2010s | 99.0% | 96.4% | 2.6% | China |
| 2020s | 97.5% | 96.5% | 1.0% | China |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hepatitis b (hepb3) immunization coverage among 1-year-olds (%), China or Singapore?
- China, at 96.0% against 96.0% in Singapore as of 2025.
- What is the difference in hepatitis b (hepb3) immunization coverage among 1-year-olds (%) between China and Singapore?
- 0.0%, with China ahead.
- How many years of comparable data are there for China and Singapore?
- 26 years are reported by both, from 2000 to 2025.
- How do China and Singapore rank globally for hepatitis b (hepb3) immunization coverage among 1-year-olds (%)?
- China ranks 40th and Singapore ranks 40th of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hepatitis B (HepB3) immunization coverage among 1-year-olds (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.